MSLN and neoplasm: The gavo-cel TRuC construct is then cloned into a lentiviral backbone, which, upon transduction into T cells, integrates into and reprograms native CD3 complexes to become activated upon recognition of tumor cell surface mesothelin in a human leukocyte antigen (HLA)-independent manner (Fig. 1a)25.